Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Iressa Drug Failure Deals AstraZeneca Fresh Blow AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer 
